These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

192 related items for PubMed ID: 31521413

  • 21. A reactive vaccination campaign with single dose oral cholera vaccine (OCV) during a cholera outbreak in Cameroon.
    Amani A, Tatang CA, Bayiha CN, Woung M, Ngo Bama S, Nangmo A, Mbang MA, Epee Douba E.
    Vaccine; 2021 Feb 22; 39(8):1290-1296. PubMed ID: 33494966
    [Abstract] [Full Text] [Related]

  • 22. Mass vaccination with a two-dose oral cholera vaccine in a long-standing refugee camp, Thailand.
    Phares CR, Date K, Travers P, Déglise C, Wongjindanon N, Ortega L, Bhuket PR.
    Vaccine; 2016 Jan 02; 34(1):128-33. PubMed ID: 26549363
    [Abstract] [Full Text] [Related]

  • 23. Considerations for oral cholera vaccine use during outbreak after earthquake in Haiti, 2010-2011.
    Date KA, Vicari A, Hyde TB, Mintz E, Danovaro-Holliday MC, Henry A, Tappero JW, Roels TH, Abrams J, Burkholder BT, Ruiz-Matus C, Andrus J, Dietz V.
    Emerg Infect Dis; 2011 Nov 02; 17(11):2105-12. PubMed ID: 22099114
    [Abstract] [Full Text] [Related]

  • 24. Achieving coordinated national immunity and cholera elimination in Haiti through vaccination: a modelling study.
    Lee EC, Chao DL, Lemaitre JC, Matrajt L, Pasetto D, Perez-Saez J, Finger F, Rinaldo A, Sugimoto JD, Halloran ME, Longini IM, Ternier R, Vissieres K, Azman AS, Lessler J, Ivers LC.
    Lancet Glob Health; 2020 Aug 02; 8(8):e1081-e1089. PubMed ID: 32710864
    [Abstract] [Full Text] [Related]

  • 25. Oral cholera vaccine delivery strategy in India: Routine or campaign?-A scoping review.
    Ray A, Sarkar K, Haldar P, Ghosh R.
    Vaccine; 2020 Feb 29; 38 Suppl 1():A184-A193. PubMed ID: 31377080
    [Abstract] [Full Text] [Related]

  • 26. Use of oral cholera vaccine in Haiti: a rural demonstration project.
    Ivers LC, Teng JE, Lascher J, Raymond M, Weigel J, Victor N, Jerome JG, Hilaire IJ, Almazor CP, Ternier R, Cadet J, Francois J, Guillaume FD, Farmer PE.
    Am J Trop Med Hyg; 2013 Oct 29; 89(4):617-624. PubMed ID: 24106187
    [Abstract] [Full Text] [Related]

  • 27. Cholera vaccination in urban Haiti.
    Rouzier V, Severe K, Juste MAJ, Peck M, Perodin C, Severe P, Deschamps MM, Verdier RI, Prince S, Francois J, Cadet JR, Guillaume FD, Wright PF, Pape JW.
    Am J Trop Med Hyg; 2013 Oct 29; 89(4):671-681. PubMed ID: 24106194
    [Abstract] [Full Text] [Related]

  • 28. Pre-emptive oral cholera vaccine (OCV) mass vaccination campaign in Cuamba District, Niassa Province, Mozambique: feasibility, vaccination coverage and delivery costs using CholTool.
    Elias Chitio JJ, Baltazar CS, Langa JP, Baloi LD, Mboane RBJ, Manuel JA, Assane S, Omar A, Manso M, Capitine I, Van Rensburg C, Luiz N, Mogasale V, Marks F, Park SE, Beck NS.
    BMJ Open; 2022 Sep 07; 12(9):e053585. PubMed ID: 36547726
    [Abstract] [Full Text] [Related]

  • 29. Long-term effectiveness of one and two doses of a killed, bivalent, whole-cell oral cholera vaccine in Haiti: an extended case-control study.
    Franke MF, Ternier R, Jerome JG, Matias WR, Harris JB, Ivers LC.
    Lancet Glob Health; 2018 Sep 07; 6(9):e1028-e1035. PubMed ID: 30103980
    [Abstract] [Full Text] [Related]

  • 30. Oral cholera vaccination strategy: Self-administration of the second dose in urban Dhaka, Bangladesh.
    Khan AI, Islam MS, Islam MT, Ahmed A, Chowdhury MI, Chowdhury F, Siddik MAU, Clemens JD, Qadri F.
    Vaccine; 2019 Feb 04; 37(6):827-832. PubMed ID: 30639459
    [Abstract] [Full Text] [Related]

  • 31. Current and future cholera vaccines.
    Shaikh H, Lynch J, Kim J, Excler JL.
    Vaccine; 2020 Feb 29; 38 Suppl 1():A118-A126. PubMed ID: 31879125
    [Abstract] [Full Text] [Related]

  • 32. Highly targeted cholera vaccination campaigns in urban setting are feasible: The experience in Kalemie, Democratic Republic of Congo.
    Massing LA, Aboubakar S, Blake A, Page AL, Cohuet S, Ngandwe A, Mukomena Sompwe E, Ramazani R, Allheimen M, Levaillant P, Lechevalier P, Kashimi M, de la Motte A, Calmejane A, Bouhenia M, Dabire E, Bompangue D, Kebela B, Porten K, Luquero F.
    PLoS Negl Trop Dis; 2018 May 29; 12(5):e0006369. PubMed ID: 29734337
    [Abstract] [Full Text] [Related]

  • 33. Euvichol-plus vaccine campaign coverage during the 2017/2018 cholera outbreak in Lusaka district, Zambia: a cross-sectional descriptive study.
    Mukonka VM, Sialubanje C, Matapo BB, Chewe O, Ngomah AM, Ngosa W, Hamoonga R, Sinyange N, Mzyece H, Mazyanga L, Bakyaita N, Kapata N.
    BMJ Open; 2023 Oct 05; 13(10):e070796. PubMed ID: 37798024
    [Abstract] [Full Text] [Related]

  • 34. Oral cholera vaccine coverage in hard-to-reach fishermen communities after two mass Campaigns, Malawi, 2016.
    Sauvageot D, Saussier C, Gobeze A, Chipeta S, Mhango I, Kawalazira G, Mengel MA, Legros D, Cavailler P, M'bang'ombe M.
    Vaccine; 2017 Sep 12; 35(38):5194-5200. PubMed ID: 28803712
    [Abstract] [Full Text] [Related]

  • 35. Cost Evaluation of a Government-Conducted Oral Cholera Vaccination Campaign-Haiti, 2013.
    Routh JA, Sreenivasan N, Adhikari BB, Andrecy LL, Bernateau M, Abimbola T, Njau J, Jackson E, Juin S, Francois J, Tohme RA, Meltzer MI, Katz MA, Mintz ED.
    Am J Trop Med Hyg; 2017 Oct 12; 97(4_Suppl):37-42. PubMed ID: 29064362
    [Abstract] [Full Text] [Related]

  • 36. The reactive vaccination campaign against cholera emergency in camps for internally displaced persons, Borno, Nigeria, 2017: a two-stage cluster survey.
    Ngwa MC, Alemu W, Okudo I, Owili C, Ugochukwu U, Clement P, Devaux I, Pezzoli L, Oche JA, Ihekweazu C, Sack DA.
    BMJ Glob Health; 2020 Jun 12; 5(6):. PubMed ID: 32601092
    [Abstract] [Full Text] [Related]

  • 37. Effectiveness of the Euvichol® oral cholera vaccine at 2 years: A case-control and bias-indicator study in Haiti.
    Matias WR, Guillaume Y, Cene Augustin G, Vissieres K, Ternier R, Slater DM, Harris JB, Franke MF, Ivers LC.
    Int J Infect Dis; 2024 Feb 12; 139():153-158. PubMed ID: 38000510
    [Abstract] [Full Text] [Related]

  • 38. Sociocultural determinants of anticipated oral cholera vaccine acceptance in three African settings: a meta-analytic approach.
    Sundaram N, Schaetti C, Merten S, Schindler C, Ali SM, Nyambedha EO, Lapika B, Chaignat CL, Hutubessy R, Weiss MG.
    BMC Public Health; 2016 Jan 14; 16():36. PubMed ID: 26762151
    [Abstract] [Full Text] [Related]

  • 39. Effectiveness of a killed whole-cell oral cholera vaccine in Bangladesh: further follow-up of a cluster-randomised trial.
    Ali M, Qadri F, Kim DR, Islam MT, Im J, Ahmmed F, Khan AI, Zaman K, Marks F, Kim JH, Clemens JD.
    Lancet Infect Dis; 2021 Oct 14; 21(10):1407-1414. PubMed ID: 34146473
    [Abstract] [Full Text] [Related]

  • 40. Controlling cholera in the Ouest Department of Haiti using oral vaccines.
    Kirpich A, Weppelmann TA, Yang Y, Morris JG, Longini IM.
    PLoS Negl Trop Dis; 2017 Apr 14; 11(4):e0005482. PubMed ID: 28410382
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.